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We have examined the eﬀect of stearylamine (SA) in liposomes on the viability of Plasmodium falciparum in culture by
studying the inhibition of incorporation of [3H]-hypoxanthine in the nucleic acid of parasites. Stearylamine in liposomes
signiﬁcantly inhibits the growth of the parasites depending on the phospholipids composition. The maximum inhibition was
observed when SA was delivered through Soya phosphatidylcholine (SPC) liposomes. The chain length of alkyl group and
density of SA in liposomes play a signiﬁcant role in inhibiting the growth of the parasites. Incorporation of either cholesterol
or Distearylphosphatidylethanolamine−Methoxy-Polyethylene glycol-2000 (DSPE-mPEG-2000) in Soya phosphatidylcholine-
stearylamine (SPC-SA) liposomes improves the eﬃcacy. Intraerythrocytic entry of intact SPC-SA liposomes into infected
erythrocytes was visualized using ﬂuorescent microscopy. No hemolysis was observed in uninfected erythrocytes, and slight
hemolysis was noted in infected erythrocytes at high concentrations of SPC-SA liposomes. Overall, our data suggested SA in
SPC-liposomes might have potential application in malaria chemotherapy.
1.Introduction
Malaria, a protozoan parasitic infection, is considered to
be one of the most prevalent parasitic diseases aﬄicting
the subtropical countries [1]. The quinoline group of
antimalarial drugs such as chloroquine (CQ), meﬂoquine,
and primaquine has been until recently, shown to be the
most eﬀective drugs for malaria chemotherapy because of
their rapid onset of action and most important, their cost
eﬀectiveness, which have encouraged their wide use [2].
With the onset of CQ-resistant parasites, attempts have
been made by several investigators to deliver chloroquine
throughliposomesforthetreatmentofchloroquine-resistant
malaria [3–6]. The focus was also shifted either to develop
novel chemotherapeutics or new modes of antimalarial
drug delivery to overcome drug resistance mechanisms of
the parasite [7]. Dramatic changes in the functional and
structural characteristics of infected red blood cells (RBCs)
are observed with Plasmodium infection and maturation.
The alterations in lipid and protein composition-resulting
from disturbance in membrane structure and function,
ultimately lead to increased membrane ﬂuidity [8]. The
formation of “new permeable pathways” (NPPs) allows the
entry oflow molecular weight as well as nanosized molecules
selectively to the parasitized RBCs [9, 10].
It has been previously reported by a number of inves-
tigators that liposomes consisting of stearylamine (SA)
and phosphatidylcholine (PC) have antiprotozoan activ-
ity towards a number of pathogenic protozoan parasites
like Trypanosoma cruzi [11],T .b r u c e ig a m b i e n s e[12],
Toxoplasma gondii [13], and Leishmania donovani [14].
The aim of this study was to evaluate the antimalar-
ial eﬀect of SA-intercalated PC liposomes on infected
erythrocytes in culture. The eﬀect of various liposomal
components/constituents like phospholipids, the density of
cholesterol, density and chain length of alkyl group of
SA, and DSPE-mPEG-2000 which are known to inﬂuence
signiﬁcantly the eﬃcacy of liposomal drugs, was coherently
studied. Fluorescent analogue of SA (octadecylrhodamine)
was used both as a marker for SA intercalation as well as2 Journal of Parasitology Research
a tracking molecule to visualize the entry of SPC-SA (Soya
phosphatidylcholine-Stearylamine) liposome into infected
RBC.
2.Methods
2.1. Chemicals. All chemicals were obtained from Sigma
Chemical Co., St. Louis, Mo, USA or GIBCO BRL, Gaithers-
burg, Md, USA unless otherwise indicated. Soya Phos-
phatidylcholine (SPC) was obtained as a gift from Lifecare
Innovations Pvt. Ltd., Gurgoan, India. DSPE-mPEG-2000
(Distearoyl phosphatidyl ethanolamine-Methoxy-Polyethy-
lene glycol-2000) was purchased from Avanti Polar Lipids,
Inc., Alabaster, Ala, USA. Hypoxanthine Monohydrochlo-
ride, [3H(G)] was bought from American Radiolabeled
Chemicals, Inc., St. Louis, Mo, USA. Human O+ serum was
obtained from Innovative Research, Inc., Peary Court Novi,
Mich, USA.
A ﬂuorescent amine analogue, octadecylrhodamine was
purchased from Invitrogen Corp., Grand Island, NY, USA.
Thestocksolutionwaspreparedbydissolving thecompound
at 1.25mM in ethanol and was stored at −20◦Cp r o t e c t e d
from light.
2.2. In Vitro Culture ofPlasmodium falciparum. The strain of
Plasmodium falciparum used in the study was 3D7 obtained
from National Institute of Malarial Research, New Delhi,
India. This strain was maintained (a modiﬁed method
of Trager and Jensen [15]) by serial passages in human
erythrocytesculturedat4%hematocritinRPMI-1640media
supplemented with 10% human serum and incubated at
37◦C under the atmosphere of mixed gas (containing 5%
CO2,5 %O 2, and 90% N2) in a plastic chamber. Heparinized
whole O+ blood was collected from Rotary Blood Bank, New
Delhi, and RBCs were separated under sterile conditions by
centrifugation to remove serum and buﬀyc o a t .T h el e v e l so f
parasitemia were routinely monitored on blood smear with
5% Giemsa azure type B stain in phosphate buﬀer (20mM,
pH 7.2). For each experiment, samples of the stock culture
were further diluted in culture medium up to 2% hematocrit
and parasitemia of 1% in preparation for the addition to
microtitration plates.
2.3. Liposomes Preparation. Liposomes were prepared by the
hand-shak method as described earlier [16]. Brieﬂy, SPC or
EPC (Egg phosphatidylcholine) alone or with either SA or
PA (Phosphatidic acid) in a molar ratio of 80:20 (40µmole
total lipids) and trace amount of octadecylrhodamine (R18)
(41nmoles/40nmoles total lipid), as a marker for estimation
of SA intercalation, was dissolved in chloroform (2-3mL) in
100mL round-bottomﬂask. The chloroformwas evaporated
to dryness at 30◦C, under reduced pressure, by using rotary
evaporator. The thin ﬁlm, so formed, was desiccated for
1h, followed by hydration with 1ml phosphate buﬀer saline
(PBS 20mM, pH 7.2) for overnight at 4◦C. On the following
day, liposomes were sonicated at 25◦Cf o r3 0 m i ni na
bath-type sonicator (Branson 1510) at 40kHz and extruded
through 100nm polycarbonate membrane. The liposomal
SA was separated from free SA by ultracentrifugation
(Beckman coulter ultracentrifuge, 300,000×g, 40min, 4◦C).
The pellet was suspended in 1ml PBS (20mM, pH 7.2)
and ﬁnally ﬁltered through 0.22µm Millex GV Millipore
membrane.Liposomescontainingstearylalcohol, stearicacid
and diﬀerent chain length fatty acids were prepared as
described above using molar ratio of SPC:other compo-
nents 80:20. The recovery of liposomes was monitored by
measuring phospholipid using Stewart’s method [17]a n d
SAwasassessed ﬂuorimetrically(excitation560nm/emission
590nm). Recovery of liposomes was found to be 60–
65% with 90–95% SA intercalated in all the liposomal
formulations. Stearically stabilized liposomes were prepared
as described above by adding various mol% (1–5mol%) of
DSPE-mPEG-2000 during the preparation of lipid ﬁlm. The
size of the liposomes was measured using Malvern Zetasizer,
Nano ZS model, and it was found in the range of 90–110nm
(Figure 1). For the preparation of ﬂuorescent labeled-
liposomes for ﬂuorescence microscopy, octadecylrhodamine
(R18) (6nmole/200nmoles total lipid) was added in SA-SPC
liposome suspension and incubated at room temperature
for 15min. Excess R18 was removed by ultracentrifugation
(300,000×g, 40min, 4◦C), and the pellet obtained was
resuspended in 20mM PBS (ﬁnal concentration 1mg/mL of
phospholipid).
2.4. Evaluation of Liposomal Antimalarial Activity. Anti-
malarial eﬀects of the diﬀerent liposomal formulations was
monitored by studying the inhibition of incorporation of
[3H]-hypoxanthine in the nucleic acid of parasites [18]. In
brief, liposomal preparations were serially diluted and added
to Plasmodium falciparum infected erythrocyte suspension
(2% ﬁnal hematocrit and 1% parasitemia) in a 96-well tissue
culture plate. After 24h of incubation at 37◦C, 0.2µCi of
[3H]-hypoxanthine was added to each well and cells were
harvested 18h later by using a Skatron Semiautomated cell
harvester. [3H]-hypoxanthine incorporation in nucleic acid
was measured in a liquid scintillation counter (Model: Tri-
Carb 2900 TR, Perkin Elmer), and inhibition of growth was
calculated by comparison with control (Control consists of
complete medium in a substitute for the test molecule.) All
data points were collected in triplicate for each experiment.
The IC50 (concentration of SA required to inhibit 50% of
growth of parasites as measured by incorporation of [3H]-
hypoxanthine) of the data was generated using Origin Cal
software (version 3).
2.5. Intracellular Accumulation of SA-Liposomes. The inter-
action of SA liposomes with infected erythrocytes was
visualized by performing a time-dependent study using
octadecylrhodamine (R18)-SPC-SA liposomes. The erythro-
cytes cultured at 2% hematocrit and high parasitemia (8–
10%) were exposed to labeled liposomes at its IC50 for 15,
30, 45, and 120min and kept at 37◦C under the mixed
gas atmosphere as mentioned previously. At the end of
incubation, unbound liposomes were washed oﬀ by brief
spin and cells were ﬁxed with a mixture of2% paraformalde-
hyde and 2.5% glutaraldehyde for 2h in 0.1M PBS at 4◦C.Journal of Parasitology Research 3
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Figure 1: Particle size determination of SPC-SA liposomes using
Malvern Zetasizer: Mean diameter of the liposomes was found to
be (a) 100nm for SPC-SA, (b) 120nm for SPC-SA-CHOL (CHOL:
Cholesterol, 20mol%), and (c) 90nm for SPC-SA-PEG (PEG,
5mol%).x-axis denotes diameter of liposomes (in nm) and y-axis
Intensity (%).
Staining ofparasites was donebyusing DAPIstain (1µg/mL)
for 30min at 37◦C and after subsequent wash cells were
visualized on a ﬂuorescent microscope (Nikon Eclipse TE
2000) using rhodamine ﬁlter 96312/G2EC (excitation 540–
525nm/emission 620–660nm) and DAPI ﬁlter (excitation
359nm/emission 461nm). Uninfected erythrocytes were
taken as control.
2.6. Assessment of Hemolytic Activity. Hemolysis was mea-
sured in SPC-SA-liposome-treated sets of cultured infected
and uninfected erythrocytes by measuring absorbance of Hb
at 405 nm (soret peak of hemoglobin (Hb)) as described
[19]. Brieﬂy, increasing concentration of liposomal prepa-
rations was added in Plasmodium falciparum infected (2%
hematocrit and 1% parasitemia) and uninfected erythrocyte
(2% hematocrit) in a 96-well plate for 42h at 37◦C. After
incubation, the plate was spun down brieﬂy and absorbance
of supernatant was measured at 405nm. Mixing the ery-
throcytes with 1% of Triton-X 100 attained the complete
hemolysis. Cells in PBS were taken as negative control.
3.Results
3.1. Eﬀects of Various Liposomes on the Viability of Plasmod-
ium falciparum In Vitro. The eﬀect of various liposomes on
the viability of Plasmodium falciparum strain 3D7 in culture
wastested(Table1).SPCliposomealoneorhavingnegatively
charged lipid, phosphatidic acid (PA), had no eﬀect on
the viability of parasites. However, SPC liposomes having
positively charged lipid, stearylamine (SA), signiﬁcantly
inhibited the growth of the parasites (IC50 = 6.87µM
(Figure 3) & 24.08µM in terms of phospholipid in Table 1).
To further dissect the role of alkyl and amino group of
SA in plasmocidal activity, SPC liposomes containing either
stearyl alcohol or stearic acid having no amine group were
prepared and tested. Eﬀect of spermidine—a polyamine
having multiple amino groups and no alkyl group—was also
examined. Stearyl moiety alone as in stearic alcohol and
stearic acid did not show any eﬀect as concluded by the lack
of antimalarial activity. Even multiple amino groups as in
spermidine had no eﬀect on growth of parasites (Table 1).
Diﬀerent chain length fatty acids and alkyl alcohols ranging
from tetradecyl to octadecyl (stearyl) did not show any
inhibitory eﬀect (Table 1). These results clearly suggest that
both alkyl and amino groups of SA are essential in the
inhibition of growth of Plasmodium falciparum in culture
as stearylalcohol without amino group and spermidine
without alkyl group but with three amino groups have no
antimalarial activity.
3.2. SA Density in Liposome Membrane Dictates Plasmocidal
Activity. After incubating the cells with liposomes loaded
with various mol% of SA, a linear increase in antimalarial
activity was observed till 20mol% (IC50 = 6.87µM) after
which there was no further enhancement. The liposomes
consisting of 5mol% SA showed very weak antimalarial
activity (IC50 = 41.15µM) (Figure 2). This indicates that
the optimum mol% of SA in liposomes to confer maximum4 Journal of Parasitology Research
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Figure 2: Eﬀect of SA density in SPC liposome on the parasite
viability: Infected human RBCs in the presence of liposome
suspension (30µM) containing 5, 10, 20, and 30mol% SA was
incubated at 37◦C for 42h as described in materials and methods.
Inset: Relationship between surface density of SA in the liposome
membrane and reciprocal of the IC50 required for killing the
parasite (1/ IC50).
killing activity was 20mol%. All subsequent experiments
were carried out using 20mole% SA in liposomes.
3.3. Role of Chain Length of Alkyl Amine on the Inhibition of
Growth of Plasmodium falciparum in Culture. Plasmodium
falciparum infected red blood cells suspension was incubated
with liposomes composed of 80% soya PC and 20% alkyl
amines of diﬀerent chain length, and their viability was
examined. The results depicted in Table II suggested that the
chain length of the alkyl group of the aliphatic amines is
directly proportional to antimalarial activity. The liposome
containing decylamine has IC50 of 43.45µMc o m p a r e dw i t h
thatofoctadecylamine (SA)having IC50 of6.87µM(T a b l e2)
suggesting that the hydrophobic portion of alkyl amine plays
a synergistic role along with the amino group in plasmocidal
activity.
3.4. Antimalarial Activity of SA Liposome Is Phospholipid
Dependent. The phospholipid is the main constituent of
liposomes and phospholipid composition of liposomes sig-
niﬁcantly inﬂuence the biological eﬃcacy of encapsulated
drugs [20]. In order to ascertain whether incorporation
of SA in diﬀerent phospholipids has any eﬀect on the
inhibition of growth of Plasmodium falciparum in human
erythrocytes in culture, we have incorporated SA in three
diﬀerent phospholipids like bovine brain sphingomyelin,
egg phosphatidylcholine, and soya phosphatidylcholine and
studieditseﬀectontheanti-malarialeﬃcacyofSAinculture.
SA in SPC and EPC liposomes with IC50 of 6.87µMa n d
7.30µM,respectively,wasequallyeﬀectiveasananti-malarial
agent (Figure 3). On the other hand, it had no eﬀect when
incorporated in sphingomyelin liposomes; clearly showing
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Figure 3: Eﬀect of diﬀerent composition of liposome on plas-
mocidal activity of SA: SPC, EPC, and sphingomyelin liposomes
containing 20mol% of SA were added in the cultured cells as
described in materials and methods. A graph of cell viability
(measured after 42h) against SA concentration provides the IC50.
that anti-malarial eﬃcacy of SA in liposomes is signiﬁcantly
dependent on the phospholipid composition of liposomes.
3.5. Incorporation of Stabilizers in SPC-SA Liposomes. It is
well known that cholesterol increases the stability of lipo-
somes in the physiological environment, and DSPE-mPEG-
2000increasesthehydrophilicityonthesurface ofliposomes,
consequently increasing the longevity of liposomes in the
blood circulation and improving the therapeutic eﬃcacy of a
number of drugs [21, 22]. In our case, incorporating choles-
terol and DSPE-mPEG-2000 in SA liposomes marginally
increased the eﬃcacy (Figures 4(a) and 4(b)) suggesting that
these liposomes can be used as a delivery vehicle for SA for
the treatment of malaria in vivo condition.
3.6.DirectEntryofSPC-SALiposomesSpeciﬁcallyintoInfected
Erythrocytes. A time-dependent study was performed to
probe the initiation of the interaction of SA liposome with
infected RBCs. After 45 minutes exposure to the SPC-
SA liposome, internalization of the liposome into infected
RBCs began, which became completely evident after 2h
of incubation (Figure 5), indicating that SPC-SA liposome
was able to ﬁnd its way through the host cell membrane.
However, uninfected erythrocytes showed the accumulation
of liposomes at their surface even after 2h of incubation
clearly suggesting that the entry of SPC-SA liposome is
moreover restricted to parasitized erythrocytes only.
3.7. Plasmocidal Activity of SPC-SA Liposome withoutHemol-
ysis. To probe the mechanism of antimalarial activity of SA
liposome, the ability to induce hemolysis of infected cells
was investigated. No hemolysis was observed in uninfected
erythrocytes. However, in infected erythrocytes at a higher
dose (60–1.88µM ) ,h e m o l y s i so fa b o u t5 %w a so b s e r v e dJournal of Parasitology Research 5
Table 1: Eﬀects of Various Liposomes on the Viability of Plasmod-
ium falciparum in vitro.
Types of liposomes
IC50 in terms of
phospholipid
concentration (µM)
SPC >208.33
SPC: PA >208.33
SPC: SA 24.08 ± 1.15
SPC: Stearic acid (octadecanoic acid) >208.33
SPC: Stearyl alcohol (octadecyl alcohol) >208.33
SPC: myristic acid ( tetradecanoic acid) >208.33
SPC: Palmitic acid (hexadecanoic acid) >208.33
SPC: myristyl alcohol (tetradecyl alcohol) >208.33
SPC: Cetyl alcohol (hexadecyl alcohol) >208.33
Free spermidine >1102
Cells with 1% parasitemia and 2% hematocrit in the presence of various
concentrations of above mentioned liposomal formulations (6.5µM–
208µM lipids) and free spermidine (34µM–1102µM) were treated for 42h
at 37◦C (in between at 24h, [3H] hypoxanthine was added). The cell-
associatedradioactivity was determined and inhibition of growth calculated
by comparison with controls (without liposomes/spermidine).
Table 2:Eﬀect ofdiﬀerentchainlengthalkylamineinSPCliposome
on parasite growth after 42h in culture.
Types of liposomes IC50 (µM)
SPC: Decylamine CH3(CH2)9NH2 43.45 ± 4.45
SPC: Dodecylamine CH3(CH2)11NH2 24.65 ± 2.69
SPC: Tetradecylamine CH3(CH2)13NH2 13.59 ± 1.64
SPC: Hexadecylamine CH3(CH2)15NH2 10.44 ± 1.20
SPC: Octadecylamine CH3(CH2)17NH2 6.87 ± 0.44
Parasites were treated with indicated alkylamine SPC liposome for 42h
with concentration range of (1.88µM–60µMa l k y l a m i n e ) .I C 50 value was
assessed by measuring [3H] hypoxanthine incorporation as described in
Materials and Methods. The mean value ± standard deviation is indicated
for each group, and values are representative of 3 separate experiments.
with the eﬀect subsiding at the IC50 value of SPC-SA
liposome (Table 3), suggesting that the antimalarial eﬀect of
these liposomes is independent of hemolysis.
4.Discussion
Several studies have reported that SA in liposomes kills a
number of pathogenic protozoan parasites in culture as well
as in animal model [11, 13, 14, 23, 24]. The results of
t h ec u r r e n ts t u d ys h o w e df o rt h eﬁ r s tt i m et h ei n h i b i t i o n
of growth and multiplication of Plasmodium falciparum by
these liposomes. It has been reported that the interaction of
liposomes with mammalian cells is signiﬁcantly dependent
on the composition, charge, size, rigidity, and hydrophilicity
on the surface of the liposomes as well as the cell types
[25]. Therefore, to examine the role of these parameters
in the antimalarial activities of SA liposomes, modiﬁers
were incorporated in SPC-SA liposomes. The maximum
inhibition was observed when SA was delivered through
soya-PC followed by egg-PC liposomes with no inhibition
Table 3: Eﬀect of various concentrations of SPC liposomes
containing 20mol% SA on the hemolysis of infected & uninfected
erythrocytes.
Concentration of
liposomes (SA)µg/mL
%H e m o l y s i s
Infected RBC
(1% parasitemia) Uninfected RBC
16.0 3.30 ± 0.34 0
8.0 1.91 ± 0.62 0
4.0 1.59 ± 0.85 0
2.0 0 0
1.0 0 0
0.5 0 0
SPC-SAliposomesatdiﬀerentconcentrationsweremixedwithinfected(1%
parasitemia) and uninfected erythrocytes for 42h as described in materials
and methods. Percentage hemolysis was calculated using the expression
%h e m o l y s i s= [A405nm (sample) − A405nm (negative control)]/A405nm
(positive control).
when SA was delivered through SM liposomes. Alone egg-
PC or soya-PC liposomes or SPC-PA liposomes were unable
to elicit any plasmocidal activity.
As stated earlier, phospholipid composition plays a
signiﬁcant role in determining the biological eﬃcacy of
encapsulated drugs in liposomes. It is known that sphin-
gomyelin (SM) forms very rigid liposomes as compared to
liposomes prepared by EPC or SPC.It has also been reported
that fusion of liposomes with mammalian cells [26], transfer
of individual lipid molecules from liposomes to the plasma
membrane of the mammalian cells or lipoproteins [27, 28]
and endocytosis of liposomes [29] are signiﬁcantly depen-
dent on the lipid composition and ﬂuidity of the liposomes.
The reduced eﬃcacy of SA in SM liposomes in inhibiting the
growth of Plasmodium falciparum as compared to EPC or
SPC liposomes may be due to reduced fusion/interaction of
rigid SM liposomes with infected erythrocytes as compared
to ﬂuid EPC or SPC liposomes.
Increasing the surface density of SA in the liposomal
membrane resultedin aprogressive increase in theinhibition
of growth of parasites, and liposomes, containing <5mol%
were possibly inactive although SA has been 90–95% inter-
calated in all the liposomal formulations. The explanation
for this observation has been attributed to polycationic
nature of SA by earlier investigators [13]. However, there
has been no report in the literature about the dependency
of the hydrophobic domain of SA. In order to answer
this question, liposomes composed of 80% soya PC and
20% alkylamines of diﬀerent chain length were prepared,
and their plasmocidal activity was examined. It was found
that increasing the chain length of the aliphatic amines
increases antimalarial activity (Table 2) suggesting that not
only polycationic surface but also the hydrophobic portion
of the alkyl amines is very important and involved in the
antimalarial activity. This may explain why polycationic
molecules, like spermidine, polylysine, polyhistidine, and
polymyxin B that lacks hydrophobic domain, are unable to
kill parasites.6 Journal of Parasitology Research
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Figure 4: Eﬀect of density of cholesterol or DSPE-mPEG-2000 in SPC-SA liposome on plasmocidal activity: cells (1% parasitemia and
2% hematocrit) in the presence of increasing concentrations (1.88µM–60µM SA) of SPC-SA liposome containing diﬀerent density of (a)
cholesterol (5, 10, 15, and 20mol%) (b) DSPE-mPEG-2000 (1, 1.25, and 5mol %) cultured for 42h at 37◦C. The results are expressed as a
percentage of the incorporation of the radioactive precursors as compared to controls incubated in the absence of any liposome.
The mechanism by which SPC-SA liposomes kill malaria
parasite is not well understood at present. But reports
suggest that these liposomes kill other protozoan parasites
by direct interaction with the negatively charged surface
moleculesoftheparasites[24].Now,questionishowmalaria
parasite infected mature red blood cell, which is a terminally
diﬀerentiated cell and lacks endocytic activity, internalized
positively charged SA incorporated into SPC liposomes?
Infection of human erythrocytes by the malarial parasites,
Plasmodium falciparum, results in complex membrane sort-
ing and signaling events in the mature erythrocytes [30].
Host-signaling components in combination with parasite
protein makes the intraerythrocytic environment conducive
to induce formation of the membrane surrounding malaria
vacuole [31]. Erythrocytes membrane contain detergent-
resistant membrane (DRM) raft, which contains many pro-
teins, and some of these proteins (minor DRM proteins) are
enriched in the parasitophorousvacuolar membrane formed
by the malaria parasite as it enter the erythrocytes [32].
These results suggest that entry of erythrocyte membrane
protein into the cytosol occurs through membrane invagi-
nation in malaria-infected erythrocytes. It has also been
reported that once inside the erythrocytes, malaria parasite
remodels the erythrocyte membrane creating a number of
transport pathways for importing nutrient molecules from
the circulation rendering it more permissive for malaria
parasite survival [33–35]. Reports suggested that channels
called “New Permeability Pathways” or NPPs appear after
12–16h of Plasmodium invasion, and small molecules (MW
< 200Da) gained access to the parasite through it [9, 10].
It has also been reported that parasite has direct access to
extracellular nanosized (80nm) latex bead particles[36]. To
understand the mechanism of internalization of SPC-SA
liposomes, we have tracked entry of octadecylrhodamine-
SA liposomes (having size 90–110nm) into infected RBCs
by ﬂuorescence microcopy. It was found that octadecyl rho-
damine probe enters into the cytosol of infected erythrocytes
(Figure 5). However, the exact mechanism of entry of the
probe into cytosol and from cytosol of infected erythrocytes
into parasitophorous vacuole is not well understood.
The spontaneous transfer of the probe octadecyl rho-
damine to unlabelled membranes has been reported [37].
Further, Grellier et al. have demonstrated the existence
of the unidirectional ﬂux of lipid from HDL to the
intracellular parasites via the erythrocyte plasma mem-
brane without internalization of the lipoprotein particles
[38]. They have also demonstrated that the cytoplasm
of infected erythrocytes contains numerous vesicles and
tubular structure. Tubular structures acts as connector
between parasitophorous vacuolar membrane system and
the erythrocytes membrane for transport of lipids. Our
results suggest that both SPC and SA were transferred to the
membrane of Plasmodium-infected erythrocytes following
fusionbetweenSPC-SAliposomes andinfected erythrocytes.
Then, SA was transported from the infected erythrocytes
membrane to the parasites possibly via lateral diﬀusion
followed by fusion with complex network of membranes
occurringinthecytosolofPlasmodium-infected erythrocytesJournal of Parasitology Research 7
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SPC-SA-
rhodamine Merge DAPI Merge all
15 min
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Figure 5: Intraerythrocytic uptakeof SPC-SAliposome:parasitecultures were exposed fordiﬀerent time pointswith rhodaminatedSPC-SA
liposomes(5µg/mL)(Panel:SPC-SARhodamine) at37◦C, ﬁxed andfurther counterstainedusing DAPI (1µg/mL),andkeptindark. Images
were takenwithin5minafterexposure tomicroscopiclighttoavoidphotobleaching.Uninfected erythrocytes were alsotreated undersimilar
conditions. Panel RBC denotes phase contrast pictures of RBC, Merge denotes merger of phase contrast picture and rhodamine picture.
as reported by Grellier et al. [38].This may explain the
labeling of infected erythrocytes with octadecyl rhodamine
probe. Besides, various reports suggested that parasites take
uphemoglobinfromcytosolofRBCbyplethoraofpathways.
A well-characterized vesicular pathway for internalization
of host cytoplasm is via cytostome-derived invagination
resembling endocytosis [39, 40]. Recently, Elliott et al.
[41] showed that four diﬀerent but overlapping pathways
exist in Plasmodium falciparum for taking up hemoglobin
f r o mc y t o s o lo fR B C .T h e yh a v es h o w nt h a te a r l yr i n g -
stage parasites undergoes profound morphological changes
in which they fold like a cup onto themselves and during
this process (termed as “Big Gulp”) engulfs a large amount
of cytosol. In addition, diﬀerent processes like endocytosis
via cytostome, cytosomal tubes arising from cytostome and
phagotrophy resembling phagocytosis occur at later stages
[41]. A cytostome-mediated butvesicle-independentprocess
model of hemoglobin uptake in Plasmodium falciparum has
also been demonstrated [42]. Therefore, it is tempting to
speculate that parasite use either one or all of the above
pathways for taking membrane bound SA from cytosol.
The interaction of SA with the malaria parasite in the
parasitophorous vacuoles in erythrocytes may be facilitated
by its high negative surface charge [43].
In the present study, it is clearly demonstrated for the
ﬁrst time that SA incorporated into SPC liposomes enter
into malaria infected RBCs and are very eﬀective in the
inhibition of the growth and multiplication of the Plas-
modium falciparum within erythrocytes. The low toxicity of
these liposomes (Table 3) to the host erythrocytes may ﬁnd
SA-bearing liposomes an eﬀective means of chemotherapy
and control of Plasmodium falciparum infection in human.8 Journal of Parasitology Research
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